A systematic review of intradermal influenza vaccines

Vaccine

Volumn 29, Issue 48, 2011, Pages 8788-8801

  Young, Flora ^a   Marra, Fawziah ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Influenza vaccine; Intradermal; Systematic review

Indexed keywords

INFLUENZA VACCINE;

DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEVER; HEADACHE; HUMAN; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; MALAISE; MYALGIA; PRIORITY JOURNAL; PRURITUS; REVIEW; SHIVERING; SKIN INDURATION; SWELLING; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 82455188018     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.077     Document Type: Review

References (34)

1. Raphael D. Chapter 180. Influenza. Harrison's Principles of Internal Medicine 2008, [chapter]. http://www.accessmedicine.com/content.aspx?aID=2895663, 17ed. A.S. Fauci, E. Braunwald, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L. Jameson, J. Loscalzo (Eds.).
2. Keech D., Beardsworth M.P. The impact of influenza on working day lost: a review of the literature. Pharmacoeconomics 2008, 26(11):911-924.
3. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999, 17(Suppl. 1):S3-S10.
4. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(11):1333-1340.
5. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
6. Schanzer D.L., Tam T.W.S., Langley J.M., Winchester B.T. Influenza-attributable deaths, Canada 1990-1999. Epidemiol Infect 2007, 135:1109-1116.
7. Kwong J.C., Stukel T.A., Lim J., McGeer A.J., Upshur R.E.G., Johansen H., et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008, 5(10):1440-1452.
8. Chen Y., Wu J., Yi Q. Reduced risk of hospitalization associated with influenza vaccination in Canada. Vaccine 2010, 28:2290-2295.
9. Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20:1831-1836.
10. Demicheli V., Di Pietrantonj C., Jefferson T., Rivetti A., Rivetti D. Vaccines for preventing infl{ligature}uenza in healthy adults. Cochrane Database Syst Rev 2007, (2):CD001269.
11. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C.D., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366:1165-1174.
12. Jefferson T., Di Pietrantonj C., Al-Ansary L.A., Ferroni E., Thorning S., Thomas R.E. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, 2:CD004876.
13. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
14. McElhaney J.E., Dutz J.P. Better influenza vaccines for older people: what will it take?. J Infect Dis 2008, 198(5):632-634.
15. La Montagne J.R., Fauci A.S. Intradermal influenza vaccination-can less be more?. N Engl J Med 2004, 351(22):2330-2332.
16. Van Kerckhoven V., Van Damme P. Clinical studies assessing immunogenicity and safety of intradermally administrated influenza vaccines. Exp Opin Drug Deliv 2010, 7(9):1109-1125.
17. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17(1):1-12.
18. Arnou R., Eavis P., Pardo J.R., Ambrozaitis A., Kazek M.P., Weber F. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: randomized, controlled, phase III trial. Hum Vaccine 2010, 6(4):346-354.
19. Beran J., Ambrozaitis A., Laiskonis A., Mickuviene N., Bacart P., Calozet Y., et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009, 7:13.
20. Van Damme P., Oosterhuis-Kafeja F., Van der Wielen M., Almagor Y., Sharon O., Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009, 27(3):454-459.
21. Leroux-Roels I., Vets E., Freese R., Seiberling M., Weber F., Salamand C., et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 2008, 26(51):6614-6619.
22. Belshe R.B., Newman F.K., Wilkins K., Graham I.L., Babusis E., Ewell M., et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007, 25(37-38):6755-6763.
23. Auewarakul P., Kositanont U., Sornsathapornkul P., Tothong P., Kanyok R., Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007, 25(4):659-663.
24. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. New Engl J Med 2004, 351(22):2295-2301.
25. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. New Engl J Med 2004, 351(22):2286-2294.
26. Van Damme P., Arnou R., Kafeja F., Fiquet A., Richard P., Thomas S., et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. BMC Infect Dis 2010, 10(1):134.
27. Chuaychoo B., Wongsurakiat P., Nana A., Kositanont U., Maranetra K.N. The immunogenicity of intradermal infl{ligature}uenza vaccination in COPD patients. Vaccine 2010, 28(24):4045-4051.
28. Chi R.C., Rock M.T., Neuzil K.M. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010, 50(10):1331-1338.
29. Arnou R., Icardi G., De Decker M., Ambrozaitis A., Kazek M.P., Weber F., et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009, 27(52):7304-7312.
30. Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., Karrasch J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008, 198(5):650-658.
31. European Agency for the Evaluation of Medicinal Products. Note for guidance on harmonization of requirements for influenza vaccines. 12 March; 1997, available at: [accessed 21.06.2010]. http://www.ema.europa.eu/pdfs/human/bwp/021496en.pdf.
32. Kim Y.C., Prausnitz M.R. Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res 2011, 1:7-12.
33. Kim Y.C., Jarrahian C., Zehrung D., Mitragotri S., Prausnitz M.R. Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 2012, 351:77-112.
34. McElhaney J.E. Influenza vaccine responses in older adults. Ageing Res Rev 2001, 10:379-388.